Tadamitsu Kishimoto
12Patents
1Active
12Granted
33Portfolio score
Filing activity: Jun 15, 1989 → Dec 23, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6723319B1 | Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies | Human Necessities | 183 | Expired |
| US6225051A | Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantation | Chemistry; Metallurgy | 66 | Expired |
| US5866689A | Monoclonal antibodies to GP130 protein | Chemistry; Metallurgy | 55 | Expired |
| US5186931A | Composition and method for supporting bone marrow transplantation | Chemistry; Metallurgy | 17 | Expired |
| US5844082A | Human acute phase response factor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5126325A | Method for treating thrombocytopenia | Human Necessities | 11 | Expired |
| US5719042A | Nucleic acids encoding transcription factor APRF (acute phase response factor) | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6514725B1 | STAT function-regulatory protein | Chemistry; Metallurgy | 7 | Expired |
| US7074616B1 | Mouse CXC chemokine receptor | Human Necessities | 3 | Expired |
| US5310550A | Method of treating thrombocytopenia using human BCDF in combination with IL-3 | Human Necessities | 1 | Expired |
| US7361737B2 | Mouse CXC chemokine receptor | Human Necessities | 0 | Expired |
| US11279931B2 | Therapeutic agent for a lung disease and/or method for screening for the same | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.